Healthcare utilisation and costs associated with adherence to antipsychotics among people living with HIV/AIDS and schizophrenia: a population-based cohort study in British Columbia, Canada

OBJECTIVES: Non-adherence to antipsychotics is the greatest obstacle to treating schizophrenia. We assessed the economic and clinical impacts of adherence to antipsychotics among people living with HIV/AIDS (PLWH) and schizophrenia in British Columbia, Canada. DESIGN AND SETTING: A population-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Subedi, Sony, Nanditha, Ni Gusti Ayu, Tafessu, Hiwot M, Nathani, Hasan, St-Jean, Martin, Elefante, Julius, Patterson, Thomas L, Honer, William G, Montaner, Julio S G, Lima, Viviane D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124256/
https://www.ncbi.nlm.nih.gov/pubmed/37076145
http://dx.doi.org/10.1136/bmjopen-2022-070680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124256/
https://www.ncbi.nlm.nih.gov/pubmed/37076145
http://dx.doi.org/10.1136/bmjopen-2022-070680

Ejemplares similares